Shopping Cart
- Remove All
- Your shopping cart is currently empty
Raludotatug deruxtecan (DS-6000) is an ADC compound targeting CDH6 with anti-cancer activity, used in the study of ovarian cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $447 | In Stock | |
5 mg | $1,400 | In Stock | |
10 mg | $2,240 | In Stock | |
25 mg | $4,210 | In Stock |
Description | Raludotatug deruxtecan (DS-6000) is an ADC compound targeting CDH6 with anti-cancer activity, used in the study of ovarian cancer. |
In vitro | Raludotatug deruxtecan is an antibody-drug conjugate (ADC) targeting CDH6. Raludotatug deruxtecan showed in vitro cell growth inhibition activity in high CDH6 tumor cells, but not in low CDH6 tumor cells. [1] |
In vivo | The high cell line of CDH6 in a mouse xenograft model showed strong antitumor activity and tumor regression. Raludotatug deruxtecan showed high efficacy in PDX models. [1] |
Alias | R-DXd, MK-5909, MK5909, DS-6000a, DS-6000 |
Molecular Weight | 145.5 |
Smiles | #N/A |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.